On the public citation graph

Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease

0 signed · 88 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.21178openalex-snapshot
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
inferredcites →https://doi.org/10.1002/hep.21496openalex-snapshot
The NAFLD fibrosis score
inferredcites →https://doi.org/10.1002/hep.25593openalex-snapshot
Nonalcoholic fatty liver disease is associated with coronary artery calcification
inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
inferredcites →https://doi.org/10.1002/hep.27647openalex-snapshot
Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/hep.30946openalex-snapshot
The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH
inferredcites →https://doi.org/10.1016/0735-1097(90)90282-topenalex-snapshot
Quantification of coronary artery calcium using ultrafast computed tomography
inferredcites →https://doi.org/10.1016/j.cgh.2018.05.059openalex-snapshot
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
inferredcites →https://doi.org/10.1016/j.cgh.2018.07.039openalex-snapshot
Importance of Evaluating Cardiovascular Risk and Hepatic Fibrosis in Patients With Newly Diagnosed Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cgh.2019.05.003openalex-snapshot
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
inferredcites →https://doi.org/10.1016/j.cgh.2019.12.026openalex-snapshot
Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
inferredcites →https://doi.org/10.1016/j.cmet.2019.10.014openalex-snapshot
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/j.jacc.2013.05.019openalex-snapshot
2013 ACCF/AHA Guideline for the Management of Heart Failure
inferredcites →https://doi.org/10.1016/j.jacc.2013.11.005openalex-snapshot
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
inferredcites →https://doi.org/10.1016/j.jacc.2018.05.027openalex-snapshot
Coronary Calcium Score and Cardiovascular Risk
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.013openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
inferredcites →https://doi.org/10.1038/nrgastro.2013.171openalex-snapshot
The global NAFLD epidemic
inferredcites →https://doi.org/10.1038/s41598-020-57894-yopenalex-snapshot
Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
inferredcites →https://doi.org/10.1053/j.gastro.2015.04.043openalex-snapshot
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2018.04.034openalex-snapshot
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
inferredcites →https://doi.org/10.1053/j.gastro.2018.12.036openalex-snapshot
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1111/apt.13405openalex-snapshot
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
inferredcites →https://doi.org/10.1111/apt.15660openalex-snapshot
Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1136/gutjnl-2016-311854openalex-snapshot
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
inferredcites →https://doi.org/10.1136/gutjnl-2017-313884openalex-snapshot
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
inferredcites →https://doi.org/10.1136/gutjnl-2018-317666openalex-snapshot
Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study
inferredcites →https://doi.org/10.1161/circulationaha.107.699579openalex-snapshot
General Cardiovascular Risk Profile for Use in Primary Care
inferredcites →https://doi.org/10.1371/journal.pone.0115403openalex-snapshot
LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
inferredcites →https://doi.org/10.3350/cmh.2018.0037openalex-snapshot
Recent research trends and updates on nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.3350/cmh.2019.0019nopenalex-snapshot
Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years
inferredcites →https://doi.org/10.3390/diagnostics10030129openalex-snapshot
Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4826078openalex-extracted
Liver Stiffness, Liver Function and Subsequent Metabolic Syndrome in NAFLD Associated Subclinical Atherosclerosis: Perspective from Mediation Analysis
inferred← citeshttps://doi.org/10.1002/alz.12795openalex-snapshot
Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study
inferred← citeshttps://doi.org/10.1002/poh2.6openalex-snapshot
MRI in liver cirrhosis
inferred← citeshttps://doi.org/10.1007/s00109-024-02448-2openalex-snapshot
Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review
inferred← citeshttps://doi.org/10.1007/s00261-022-03597-zopenalex-snapshot
Magnetic resonance elastography: from invention to standard of care
inferred← citeshttps://doi.org/10.1007/s11307-024-01919-9openalex-snapshot
Molecular Imaging of Fibroblast Activation in Rabbit Atherosclerotic Plaques: a Preclinical PET/CT Study
inferred← citeshttps://doi.org/10.1007/s12072-023-10517-wopenalex-snapshot
Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.aej.2025.04.066openalex-snapshot
Heart failure prognosis risk assessment model based on multimodal data fusion and IoT device monitoring
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.06.042openalex-snapshot
Liver Fibrosis in Asians With Metabolic Dysfunction–Associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cgh.2022.11.031openalex-snapshot
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.diabres.2022.109208openalex-snapshot
Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jacl.2026.02.012openalex-snapshot
Effects of pemafibrate on liver fibrosis in patients with MASLD and hypertriglyceridemia: A 2-year retrospective observational study using MR elastography
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.05.046openalex-snapshot
Liver disease is a significant risk factor for cardiovascular outcomes – A UK Biobank study
inferred← citeshttps://doi.org/10.1016/j.molmed.2021.10.005openalex-snapshot
Linking liver metabolic and vascular disease via bile acid signaling
inferred← citeshttps://doi.org/10.1016/j.yjmcc.2021.10.007openalex-snapshot
NAFLD as a continuous driver in the whole spectrum of vascular disease
inferred← citeshttps://doi.org/10.1038/s41598-024-74287-7openalex-snapshot
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification
inferred← citeshttps://doi.org/10.1055/a-1930-6658openalex-snapshot
Shared Mechanisms between Cardiovascular Disease and NAFLD
inferred← citeshttps://doi.org/10.1080/14737159.2021.1964958openalex-snapshot
Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice
inferred← citeshttps://doi.org/10.1093/bjr/tqag112openalex-snapshot
Imaging biomarkers for cardiometabolic risk stratification in metabolic dysfunction-associated steatotic liver disease: incremental value of coronary artery calcification, epicardial adipose tissue, controlled attenuation parameter, and liver stiffness measurement beyond clinical scores
inferred← citeshttps://doi.org/10.1111/apt.16350openalex-snapshot
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non‐alcoholic fatty liver disease—simply associated or more complicated?
inferred← citeshttps://doi.org/10.1111/apt.16364openalex-snapshot
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non‐alcoholic fatty liver disease—simply associated or more complicated? Authors' reply
inferred← citeshttps://doi.org/10.1111/apt.16435openalex-snapshot
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non‐alcoholic fatty liver disease—the role for non‐invasive testing
inferred← citeshttps://doi.org/10.1111/apt.16462openalex-snapshot
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non‐alcoholic fatty liver disease—a realm for non‐invasive testing. Authors' reply
inferred← citeshttps://doi.org/10.1111/apt.16771openalex-snapshot
Letter: predictive role of magnetic resonance elastography in chronic liver disease – still a long way to go
inferred← citeshttps://doi.org/10.1111/apt.16791openalex-snapshot
Letter: predictive role of magnetic resonance elastography in chronic liver disease—still a long way to go. Authors' reply
inferred← citeshttps://doi.org/10.1111/apt.17564openalex-snapshot
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
inferred← citeshttps://doi.org/10.1111/apt.17617openalex-snapshot
Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/apt.17869openalex-snapshot
Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
inferred← citeshttps://doi.org/10.1111/dom.15760openalex-snapshot
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
inferred← citeshttps://doi.org/10.1111/dom.16584openalex-snapshot
Association of device measured physical activity with liver fat and stiffness in people with type 1 diabetes
inferred← citeshttps://doi.org/10.1111/ene.15437openalex-snapshot
Association between liver fibrosis and incident dementia in the UK Biobank study
inferred← citeshttps://doi.org/10.1111/liv.15480openalex-snapshot
Performance of the Pooled Cohort Equations in non‐alcoholic fatty liver disease: The Multi‐Ethnic Study of Atherosclerosis
inferred← citeshttps://doi.org/10.1111/liv.15538openalex-snapshot
Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study
inferred← citeshttps://doi.org/10.1111/liv.15801openalex-snapshot
Liver stiffness as a cornerstone in heart disease risk assessment
inferred← citeshttps://doi.org/10.1152/ajpgi.00058.2021openalex-snapshot
Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk
inferred← citeshttps://doi.org/10.1152/physiol.00013.2023openalex-snapshot
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
inferred← citeshttps://doi.org/10.1161/jaha.123.035371openalex-snapshot
Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
inferred← citeshttps://doi.org/10.1186/s12889-025-23883-xopenalex-snapshot
Prognostic value of FIB-4 and NFS for cardiovascular events in patients with and without NAFLD
inferred← citeshttps://doi.org/10.1186/s12933-024-02161-xopenalex-snapshot
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
inferred← citeshttps://doi.org/10.1186/s12933-025-02705-9openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study
inferred← citeshttps://doi.org/10.1186/s12937-026-01342-6openalex-snapshot
Association between high-risk metabolic dysfunction-associated steatohepatitis and ischemic heart disease: a nationally representative study
inferred← citeshttps://doi.org/10.1371/journal.pone.0266965openalex-snapshot
Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study
inferred← citeshttps://doi.org/10.1371/journal.pone.0286882openalex-snapshot
Non-invasive assessment of steatohepatitis indicates increased risk of coronary artery disease
inferred← citeshttps://doi.org/10.14309/ajg.0000000000003595openalex-snapshot
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.20517/mtod.2022.23openalex-snapshot
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
inferred← citeshttps://doi.org/10.20517/mtod.2024.34openalex-snapshot
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
inferred← citeshttps://doi.org/10.2147/cia.s295524openalex-snapshot
NAFLD in the Elderly
inferred← citeshttps://doi.org/10.2214/ajr.23.29437openalex-snapshot
MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis
inferred← citeshttps://doi.org/10.3389/fsurg.2022.1072908openalex-snapshot
The predictive value of revised diastolic dysfunction in outcomes of liver transplantation: A propensity score matching analysis
inferred← citeshttps://doi.org/10.3390/diagnostics14202305openalex-snapshot
Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms222111629openalex-snapshot
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
inferred← citeshttps://doi.org/10.3390/livers6040071openalex-snapshot
From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
inferred← citeshttps://doi.org/10.3390/medicina59020375openalex-snapshot
Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/nu13103400openalex-snapshot
Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus
inferred← citeshttps://doi.org/10.4254/wjh.v18.i3.113284openalex-snapshot
Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease
inferred← citeshttps://doi.org/10.5114/pg.2021.109063openalex-snapshot
Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.